Clinical Trial Update: Chinese PD-LRRK2 Registry

View source ↗

Summary

This entry updates that the Chinese PD-LRRK2 Registry is currently recruiting participants with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Parkinson Disease | Status: RECRUITING